Epidemiological characteristics of invasive Aspergillus isolates: morphology, drug susceptibility, and mutations in azole drug targets

Abstract Background The global epidemiology of aspergillosis varies and is influenced by various factors. To elucidate the disease burden and identify effective control strategies, the epidemiological characteristics of Aspergillus infections have to be investigated. The aim of this study was to assess the epidemiological characteristics of various Aspergillus species, including their morphological features, species identification, and in vitro susceptibility to nine antifungal agents in a large tertiary hospital in northern China. Methods Ninety-five clinical isolates of Aspergillus were collected from patients. Aspergillus species identification was performed using conventional morphological methods, MALDI-TOF MS, and gene sequencing. In vitro susceptibility to nine antifungal agents was evaluated using the Sensititre YeastOne system. Target genes (cyp51A and cyp51b) of A. tubinazole were sequenced using the Sanger method. Results Aspergillus fumigatus, A. niger, A. flavus, A. tubingensis, and A. terreus were the most common isolated species. Rare species included A. tamarii, A. usamil, A. versicolor, A. udagawae, A. lentulus, A. sydowii, and A. quadrilineatus. Pulmonary infections accounted for 86.3% (82/95) of collected cases, and the in-hospital mortality rate was 22.1%. The median minimum inhibitory concentration (MIC) range of amphotericin B was 1.5–4 mg/L. The MIC range of triazoles against Aspergillus species, excluding A. udagawae and A. lentulus, was 0.12–0.5 mg/L. The median minimum effective concentration range of echinocandins was A. fumigatus isolates, and non-wild-type resistance to voriconazole was observed in 11.1% (1/9) of A. tubingensis isolates. Moreover, cyp51A and cyp51b of A. tabinensis had 2–29 and 10–13 nucleotide mutations, respectively. Conclusion Patients with non-A. fumigatus infection accounted for 43.2%. The T256A amino acid substitution in cyp51A of A. tabinensis did not lead to increased azole drug MICs.